Showing 381 - 400 results of 10,572 for search '"tumors"', query time: 0.09s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384
  5. 385
  6. 386
  7. 387

    Carbon Material Hybrid Construction on an Aptasensor for Monitoring Surgical Tumors by Renyuan Ma, Subash C. B. Gopinath, Thangavel Lakshmipriya, Yeng Chen

    Published 2022-01-01
    “…Carcinoembryonic antigen (CEA) is a glycoprotein, one of the common tumor biomarkers, found at low levels in body fluids. …”
    Get full text
    Article
  8. 388

    Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors by Callisia N. Clarke, Paul Cockrum, Thomas J.R. Beveridge, Michelle Jerry, Donna McMorrow, Anh Thu Tran, Alexandria T. Phan

    Published 2023-12-01
    “…**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-based management of NETs. …”
    Get full text
    Article
  9. 389

    Role of exosomes in diagnosis, prognostication, and treatment of pediatric solid tumors by Shaikh M. Ghufran, Morgan L. Brown, Elizabeth A. Beierle

    Published 2025-03-01
    “…Cancer is the second leading cause of death in children, and solid tumors make up 30% of childhood cancers. Molecular profiling of pediatric solid tumors allows a personalized approach to therapy, but this approach mostly relies on surgical biopsy, which is invasive and carries the risk of complications. …”
    Get full text
    Article
  10. 390
  11. 391
  12. 392
  13. 393
  14. 394
  15. 395
  16. 396
  17. 397

    Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors by Guihong Yang, Yimei Wang, Huimin Zhao, Ziyi Jiang, Shansong Zheng, Mingjing Ge, Meimei Si, Xiaoyan Kang

    Published 2025-01-01
    “…Plasma concentration–time data were collected from 392 participants (16 healthy volunteers and 372 patients with solid tumors) who received single or multiple doses of iruplinalkib in four trials. …”
    Get full text
    Article
  18. 398

    Advances in sodium-glucose transporter protein 2 inhibitors and tumors by Jiaqi Wang, Wenyong Yang

    Published 2025-02-01
    “…Although the clinical application of targeted therapy and immunotherapy has improved the status quo of tumor treatment, the development of new therapeutic tools for tumors is still necessary. …”
    Get full text
    Article
  19. 399
  20. 400